首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 基因疗法

市场调查报告书

商品编码

1953988

日本基因治疗市场报告：按基因类型、载体类型、递送方式、应用和地区划分（2026-2034年）

Japan Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 141 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本基因治疗市场规模达3.918亿美元。 IMARC集团预测，到2034年，该市场规模将达到12.248亿美元，2026年至2034年的复合年增长率（CAGR）为13.10%。遗传疾病的日益增加、基因编辑技术的最新进展、日本政府的支持性政策以及研发投入的增加是推动市场成长的主要因素。

基因疗法是一种突破性的医疗方法，旨在透过修改个别细胞内的基因来治疗甚至根除疾病。这项先进技术涉及在患者细胞内引入、删除或改变遗传物质，主要用于纠正导致各种疾病的基因异常。基因疗法的关键组成部分包括治疗性去氧核糖核酸（DNA）、将DNA导入细胞的递送载体以及CRISPR等先进的基因编辑技术。其潜在应用包括癌症治疗、病毒感染疾病控制、心血管疾病（CVD）、神经系统疾病、自体免疫疾病、老龄化相关疾病、某些类型的失明以及血友病、囊肿纤维化和镰状细胞贫血等遗传性疾病。

日本基因治疗市场的发展趋势：

日本遗传性疾病和癌症的日益普遍推动了对基因治疗等创新治疗方法的需求，进而促进了市场成长。此外，CRISPR/Cas9等基因编辑技术的最新进展提高了基因修饰的精确度和治疗成功率，进一步促进了市场成长。製药和生物技术公司为开发高效创新的基因治疗方法而投入大量资金进行研发，也推动了市场成长。同时，日本政府实施了一系列支持性的监管和政策措施，加速基因疗法的核准流程，促进临床试验和产品的开发，也刺激了市场成长。此外，先进载体递送系统的出现提高了基因治疗的疗效，最大限度地减少了潜在的副作用，从而提供了更有效、更安全的治疗选择，也支持了市场成长。此外，医疗专业人员和患者对基因治疗及其潜在益处的认识不断提高，也增强了市场成长。除此之外，大学、研究机构和企业之间为促进创新和拓展商业化可能性而加强的策略联盟与合作，也推动了市场成长。此外，老年人口的增加也推动了市场成长，老年人容易患上各种与老龄化相关的疾病，例如帕金森氏症、骨关节炎、阿兹海默症、老龄化黄斑部病变（AMD）等。预计推动市场成长的其他因素包括医疗保健支出增加、精准医疗的日益普及以及对创新治疗方法的需求不断增长。

日本基因治疗市场细分：

基因分型分析：

抗原
细胞激素
肿瘤抑制基因
自杀基因
不足
生长因子
受体
其他的

向量类型概述：

病毒载体
腺病毒
慢病毒
逆转录病毒
腺结合病毒
单纯疱疹病毒
天花病毒
牛痘病毒
其他的
非病毒方法
裸载体和质体载体
基因枪
电穿孔
脂质体
其他的
腺病毒
慢病毒
逆转录病毒
腺结合病毒
单纯疱疹病毒
天花病毒
牛痘病毒
其他的
裸病毒和质体载体
基因癌症
电穿孔
脂质体
其他的

配送方式註意事项：

体内基因治疗
体外基因治疗

应用注意事项：

肿瘤性疾病
罕见疾病
心血管疾病
神经系统疾病
感染疾病

区域洞察：

关东地区
近畿地区
中部地区
九州和冲绳地区
东北部地区
中国地区
北海道地区
四国地区
本报告对所有主要区域市场进行了全面分析，包括关东、近畿地区、中部、九州/冲绳、东北、中国、北海道和四国地区。

竞争格局：

本报告也对日本基因治疗市场的竞争格局进行了全面分析。报告提供了竞争分析，包括市场结构、主要企业定位、关键成功策略、竞争格局概览和公司评估象限。此外，报告还提供了所有主要企业的详细概况。
本报告解答的关键问题
日本基因治疗市场目前发展状况如何？您认为未来几年它将如何发展？
新冠疫情对日本基因治疗市场产生了哪些影响？
日本基因治疗市场按基因类型分類的市场组成为何？
日本基因治疗市场依载体类型分類的组成是怎样的？
日本基因治疗市场按给药方式分類的市场组成为何？
日本基因治疗市场按应用领域是如何分類的？
请介绍日本基因治疗市场价值链的各个环节。
日本基因治疗市场的主要驱动因素和挑战是什么？
日本基因治疗市场的结构是怎么样的？主要参与者有哪些？
日本基因治疗市场竞争有多激烈？

The Japan gene therapy market size reached USD 391.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1224.8 Million by 2034, exhibiting a growth rate (CAGR) of 13.10% during 2026-2034. The escalating prevalence of genetic disorders, recent advancements in gene editing technologies, implementation of supportive policies by the Government of Japan, and the increasing investment in research and development (R&D) represent some of the key factors driving the market.

Gene therapy is a groundbreaking approach in the medical field, designed to address and potentially eradicate diseases through the modification of genes within an individual's cells. This advanced technique encompasses the introduction, deletion, or alteration of genetic material in a patient's cells, with the primary aim of rectifying the genetic anomalies causing various diseases. The essential components of gene therapy include therapeutic deoxyribonucleic acid (DNA), a delivery vector that facilitates the transfer of DNA into cells, and sophisticated gene-editing technologies, such as CRISPR. It finds application across numerous domains, including cancer treatment, management of viral infections, tackling cardiovascular diseases (CVDs), neurological disorders, autoimmune diseases, age-related illnesses, specific types of blindness, and genetic disorders, including hemophilia, cystic fibrosis, and sickle cell disease.

JAPAN GENE THERAPY MARKET TRENDS:

The escalating prevalence of genetic disorders and cancers in Japan, which has prompted the need for innovative treatment methods, such as gene therapy, is propelling the market growth. Additionally, the recent advancements in gene editing technologies such as CRISPR/Cas9, which have improved the accuracy of gene modifications and enhanced the success rates of therapies, are contributing to the market growth. Furthermore, the substantial investments in research and development (R&D) activities by pharmaceutical and biotech companies to develop effective and innovative gene therapies are boosting the market growth. Along with this, the implementation of supportive regulations and policies by the Government of Japan to accelerate approval processes and promote gene therapy trials and products is stimulating the market growth. Besides this, the emergence of advanced vector delivery systems, which improve gene therapy's efficacy and minimize potential side effects, thus ensuring more effective and safer treatment options, is supporting the market growth. Moreover, the heightened awareness about gene therapy and its potential benefits among healthcare professionals and patients is strengthening the market growth. Apart from this, the growing strategic alliances and collaborations among universities, research institutions, and companies to boost innovation and broaden the potential for commercialization are catalyzing the market growth. In addition, the escalating geriatric population, which is highly susceptible to various age-related diseases, such as Parkinson's disease, osteoarthritis, Alzheimer's disease, and age-related macular degeneration (AMD), is fueling the market growth. Other factors, including rising healthcare expenditure, growing adoption of precision medicines, and increasing demand for innovative therapies, are anticipated to drive the market growth.

JAPAN GENE THERAPY MARKET SEGMENTATION:

Gene Type Insights:

Antigen
Cytokine
Tumor Suppressor
Suicide Gene
Deficiency
Growth Factors
Receptors
Others

Vector Type Insights:

Viral Vector
Adenoviruses
Lentiviruses
Retroviruses
Adeno-Associated Virus
Herpes Simplex Virus
Poxvirus
Vaccinia Virus
Others
Non-Viral Techniques
Naked and Plasmid Vectors
Gene Gun
Electroporation
Lipofection
Others
Adenoviruses
Lentiviruses
Retroviruses
Adeno-Associated Virus
Herpes Simplex Virus
Poxvirus
Vaccinia Virus
Others
Naked and Plasmid Vectors
Gene Gun
Electroporation
Lipofection
Others

Delivery Method Insights:

In-Vivo Gene Therapy
Ex-Vivo Gene Therapy

Application Insights:

Oncological Disorders
Rare diseases
Cardiovascular Diseases
Neurological Disorders
Infectious Disease

Regional Insights:

Kanto Region
Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the Japan gene therapy market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan gene therapy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan gene therapy market?
What is the breakup of the Japan gene therapy market on the basis of gene type?
What is the breakup of the Japan gene therapy market on the basis of vector type?
What is the breakup of the Japan gene therapy market on the basis of delivery method?
What is the breakup of the Japan gene therapy market on the basis of application?
What are the various stages in the value chain of the Japan gene therapy market?
What are the key driving factors and challenges in the Japan gene therapy market?
What is the structure of the Japan gene therapy market and who are the key players?
What is the degree of competition in the Japan gene therapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Gene Therapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Gene Therapy Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Gene Therapy Market - Breakup by Gene Type

6.1 Antigen
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Cytokine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Tumor Suppressor
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Suicide Gene
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 Deficiency
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2020-2025)
- 6.5.3 Market Forecast (2026-2034)
6.6 Growth Factors
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2020-2025)
- 6.6.3 Market Forecast (2026-2034)
6.7 Receptors
- 6.7.1 Overview
- 6.7.2 Historical and Current Market Trends (2020-2025)
- 6.7.3 Market Forecast (2026-2034)
6.8 Others
- 6.8.1 Overview
- 6.8.2 Historical and Current Market Trends (2020-2025)
- 6.8.3 Market Forecast (2026-2034)

7 Japan Gene Therapy Market - Breakup by Vector Type

7.1 Viral Vector
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Adenoviruses
  - 7.1.3.2 Lentiviruses
  - 7.1.3.3 Retroviruses
  - 7.1.3.4 Adeno-Associated Virus
  - 7.1.3.5 Herpes Simplex Virus
  - 7.1.3.6 Poxvirus
  - 7.1.3.7 Vaccinia Virus
  - 7.1.3.8 Others
- 7.1.4 Market Forecast (2026-2034)
7.2 Non-Viral Techniques
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Naked and Plasmid Vectors
  - 7.2.3.2 Gene Gun
  - 7.2.3.3 Electroporation
  - 7.2.3.4 Lipofection
  - 7.2.3.5 Others
- 7.2.4 Market Forecast (2026-2034)

8 Japan Gene Therapy Market - Breakup by Delivery Method

8.1 In-Vivo Gene Therapy
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Ex-Vivo Gene Therapy
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)

9 Japan Gene Therapy Market - Breakup by Application

9.1 Oncological Disorders
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Rare Diseases
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Cardiovascular Diseases
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Neurological Disorders
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Forecast (2026-2034)
9.5 Infectious Disease
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Forecast (2026-2034)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Forecast (2026-2034)

10 Japan Gene Therapy Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Gene Type
- 10.1.4 Market Breakup by Vector Type
- 10.1.5 Market Breakup by Delivery Method
- 10.1.6 Market Breakup by Application
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Gene Type
- 10.2.4 Market Breakup by Vector Type
- 10.2.5 Market Breakup by Delivery Method
- 10.2.6 Market Breakup by Application
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Gene Type
- 10.3.4 Market Breakup by Vector Type
- 10.3.5 Market Breakup by Delivery Method
- 10.3.6 Market Breakup by Application
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Gene Type
- 10.4.4 Market Breakup by Vector Type
- 10.4.5 Market Breakup by Delivery Method
- 10.4.6 Market Breakup by Application
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Gene Type
- 10.5.4 Market Breakup by Vector Type
- 10.5.5 Market Breakup by Delivery Method
- 10.5.6 Market Breakup by Application
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Gene Type
- 10.6.4 Market Breakup by Vector Type
- 10.6.5 Market Breakup by Delivery Method
- 10.6.6 Market Breakup by Application
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Gene Type
- 10.7.4 Market Breakup by Vector Type
- 10.7.5 Market Breakup by Delivery Method
- 10.7.6 Market Breakup by Application
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Gene Type
- 10.8.4 Market Breakup by Vector Type
- 10.8.5 Market Breakup by Delivery Method
- 10.8.6 Market Breakup by Application
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Gene Therapy Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Services Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Services Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Services Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Services Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Services Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Gene Therapy Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis

14 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本基因治疗市场报告：按基因类型、载体类型、递送方式、应用和地区划分（2026-2034年）

Japan Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2026-2034

日本基因治疗市场的发展趋势：

日本基因治疗市场细分：

基因分型分析：

向量类型概述：

配送方式註意事项：

应用注意事项：

区域洞察：

竞争格局：

目录

第一章：序言

第二章：调查范围与调查方法

第三章执行摘要

第四章：日本基因治疗市场：简介

第五章：日本基因治疗市场：现况

第六章 日本基因治疗市场－依基因类型划分

第七章 日本基因治疗市场－依载体类型细分

第八章：日本基因治疗市场－依给药方式细分

第九章：日本基因治疗市场：依应用领域细分

第十章：日本基因治疗市场：依地区划分

第十一章：日本基因治疗市场：竞争格局

第十二章主要企业概况

第十三章：日本基因治疗市场：产业分析

第十四章附录